Scanbo

Scanbo is a medtech company, founded in 2017, that is developing an AI-driven, handheld medical diagnostic system aimed at the primary care market. The company was established by Ashissh Raichura, a serial entrepreneur with a background in computer science, including a Ph.D. in Cloud Computing and extensive experience in machine learning, big data, and IoT. The inspiration for Scanbo came from Raichura's personal experience caring for his father who was diagnosed with Alzheimer's, which highlighted the cumbersome and siloed nature of traditional diagnostic testing. This led him to develop a solution to make medical testing more accessible, convenient, and integrated, particularly for patients at home.

The core of Scanbo's business is a portable, point-of-care (POC) diagnostic platform. This ecosystem includes a handheld hardware device, proprietary testing strips, and software for mobile applications, all powered by machine learning algorithms. The device is designed to perform a range of tests and deliver results in under five minutes, a significant reduction from the 24-72 hour turnaround time often required for lab-based tests. Its product line is tiered, starting with a device capable of measuring eight non-invasive vitals such as blood pressure, body temperature, blood oxygen (SpO2), and a single-lead ECG, in addition to an invasive blood glucose test. The company has plans to expand the device's capabilities to include more complex blood tests using a dry chemistry platform that requires only a small sample of blood.

Scanbo targets a diverse client base, including clinics, hospitals, senior care facilities, community healthcare programs in remote areas, and insurance companies for risk assessment. The business model appears to be centered on the sale of the hardware devices and recurring revenue from consumables like proprietary test strips. The company positions its technology as a cost-effective and environmentally friendly alternative to conventional clinical methods, aiming to reduce medical waste and make monitoring more affordable, with a potential user cost as low as $20 per month. By enabling rapid, on-the-spot diagnostics, Scanbo aims to improve primary care triage, streamline hospital operations by reducing wait times, and empower healthcare providers with immediate data. The company is actively seeking regulatory approvals from bodies like the US FDA and Health Canada to market its products.

Keywords: medical diagnostics, point-of-care testing, AI healthcare, handheld medical device, clinical pathology, primary care technology, vital signs monitoring, non-invasive diagnostics, medtech, Ashissh Raichura, health-tech, remote patient monitoring, digital health, dry chemistry, medical IoT, ECG monitoring, blood glucose monitoring, telemedicine, healthcare data analytics, portable diagnostics, diagnostic platform, affordable healthcare